Aethlon medical provides update on the ability of its hemopurifier® to capture h5n1 bird flu

San diego , dec. 20, 2024 /prnewswire/ -- aethlon medical, inc. (nasdaq: aemd), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today provided a statement of its investigational medical device with respect to h5n1 avian influenza "bird flu." aethlon has recently received a number of inquiries regarding the potential utility of its hemopurifier device in the treatment of bird flu.
AEMD Ratings Summary
AEMD Quant Ranking